Literature DB >> 25942304

Combination therapy with sorafenib and radiofrequency ablation for hepatocellular carcinoma: a glimmer of light after the storm trial?

Antonio Facciorusso1, Nicola Muscatiello1, Alfredo Di Leo2, Michele Barone2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25942304     DOI: 10.1038/ajg.2015.80

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  4 in total

1.  Hepatocellular carcinoma: concomitant sorafenib promotes necrosis after radiofrequency ablation--propensity score matching analysis.

Authors:  Hiroyuki Fukuda; Kazushi Numata; Satoshi Moriya; Yu Shimoyama; Tomohiro Ishii; Akito Nozaki; Masaaki Kondo; Manabu Morimoto; Shin Maeda; Kentaro Sakamaki; Satoshi Morita; Katsuaki Tanaka
Journal:  Radiology       Date:  2014-04-02       Impact factor: 11.105

2.  Combination therapy with sorafenib and radiofrequency ablation for BCLC Stage 0-B1 hepatocellular carcinoma: a multicenter retrospective cohort study.

Authors:  Xiaobin Feng; Ruocai Xu; Xilin Du; Kefeng Dou; Xiao Qin; Jun Xu; Weidong Jia; Zhiming Wang; Hongzhi Zhao; Shufa Yang; Chenyang Guo; Tianqi Liu; Kuansheng Ma
Journal:  Am J Gastroenterol       Date:  2014-11-18       Impact factor: 10.864

3.  Sorafenib in combination with transarterial chemoembolization and radiofrequency ablation in the treatment for unresectable hepatocellular carcinoma.

Authors:  Yong Li; You-Bing Zheng; Wei Zhao; Bing Liu; Bao-Shan Hu; Xu He; Jian-Wen Huang; Li-Gong Lu
Journal:  Med Oncol       Date:  2013-09-19       Impact factor: 3.064

4.  An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies.

Authors:  Peter C Austin
Journal:  Multivariate Behav Res       Date:  2011-06-08       Impact factor: 5.923

  4 in total
  5 in total

1.  Response to Facciorusso et al.

Authors:  Xiaobin Feng; Kuansheng Ma
Journal:  Am J Gastroenterol       Date:  2015-05       Impact factor: 10.864

Review 2.  Radiofrequency ablation-combined multimodel therapies for hepatocellular carcinoma: Current status.

Authors:  Lumin Chen; Jihong Sun; Xiaoming Yang
Journal:  Cancer Lett       Date:  2015-10-22       Impact factor: 8.679

3.  A Hypoxia-Sensitive Drug Delivery System Constructed by Nitroimidazole and its Application in the Treatment of Hepatocellular Carcinoma.

Authors:  Tingting Meng; Yinghong Li; Ying Tian; Mingxing Ma; Kequan Shi; Xuwei Shang; Hong Yuan; Fuqiang Hu
Journal:  AAPS PharmSciTech       Date:  2022-06-16       Impact factor: 3.246

4.  Towards a tailored systemic therapy for liver cancer.

Authors:  Rodolfo Sacco; Antonio Facciorusso
Journal:  Ann Transl Med       Date:  2020-10

5.  The addition of radiofrequency ablation for patients receiving sorafenib: new evidence for a new standard?

Authors:  Michael Lock; Brandon M Meyers; Amol Mujoomdar
Journal:  Ann Transl Med       Date:  2021-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.